Abstract. Walker-256 carcinosarcoma cells grown in tissue culture medium containing inhibitory DNA prepared from the tumor are shown to have an unaltered growth in vitro, but a diminished capacity to produce malignant tumors on injection into the rat. Coincident with this change in virulence is the induction of tRNA methylase inhibitors in these malignant cells. Within days after the DNA is removed from the growth medium, the tRNA methylase inhibitors disappear and the oncogenicity reappears.
The oncogenicity of neoplastic cells prepared from the Walker-256 carcinosarcoma was strikingly reduced when the cells were incubated with DNA extracted from the same tumor.1 This was demonstrated by injection of the DNA-treated cells into rats. Relatively low concentrations of DNA (100 ,ug/ ml) and short incubation times (60-90 min) were required to produce this effect. Surprisingly, the molecular weight of the inhibitory DNA could also be relatively small (50,000). Heat denaturation prevented this inhibition, while treatment of the deoxyribonucleoprotein with proteolytic enzyme augmented the effect. Similarly prepared DNAs from bacteria or from various organs of other mammalian species were without comparable activity.
Subsequent removal of the nucleoprotein and fractionation of the inhibitory DNA by the Ledoux2 procedure yielded several classes, with molecular weights ranging from 50,000 to more than 5 X 106, all of which were inhibitory to the tumor cell transplantability. Treatment of the smaller fraction with DNase I (16 hr, 0.5 mg/ml, 380C) destroyed its inhibitory capacity. However, identical treatment of the higher molecular weight fractions increased the number of inhibitory molecules present.
When Walker-256 (W-256) DNA was injected into rats 24 hr prior to the injection of tumor cells, the resulting tumor-cell proliferation was not retarded. This was also the case whenever DNA was injected at a different site but at the time as the W-256 cells. From these results it appeared likely that the growth inhibition was due to a direct effect of the DNA on the tumor cell rather than on the host; consequently, we decided to examine the effect of DNA on W-256 cells in tissue culture. We were particularly concerned with any effects on tumor cell growth in vitro, tumor-cell tRNA methylase activity, and tumor-cell oncogenicity in vivo. Methods. DNA preparation: Rats were killed under ether anesthesia, 10 days after subcutaneous implantation of W-256 tumor. Whole neoplasms were removed as aseptically as possible and immediately frozen on dry ice. They were stored at -200C until processing. The first alcohol precipitate obtained by the Kay, Simmons, and Dounce' procedure was stored in 95% ethanol at -20'C. The deoxyribonucleoprotein was dissolved in sterile, buffered (pH 7.5) 0.2 M NaCl-0.02 M sodium phosphatepronase (1 mg/ml)-penicillin G (0.1 mg/ml) and incubated at 370C with constant stirring for 2 hr. The solution was brought to 1 M NaCl by the addition of the solid salt, then centrifuged at 00C for 30 min at 37,000 X g. The supernate was put on a 5 X 50-cm column of Biogel A, 200-400 mesh, 0.5 M, in a (40C) cold box, and eluted with autoclaved 1 M NaCl-0.02 M Na2HPO4 (pH 8)-penicillin G (0.1 mg/ml). 15-ml fractions were collected aseptically. Tubes with A260-A320 > 0.5 were pooled and concentrated in a Diaflo pressure dialysis system with a UM-10 membrane. Dialysis was continued for three more days at 40C in bags that had been boiled, treated with EDTA, and washed with distilled water; five changes (1-liter each) of 0.01 M sodium phosphate buffer (pH 7.4) with added penicillin G (0.1 mg/ml) were used.
UV absorbance was measured at 230, 260, 280, and 320 nm. washed in hot (90'C) 5% trichloroacetic acid while the other set was washed in cold 5% trichloroacetic acid; both sets were then washed with cold trichloroacetic acid, ethanol, and ether. The filter pads were dried and placed in vials with a toluene scintillation fluid for counting. Controls without added E. coli submethylated tRNA and blanks without enzyme were also assayed.
Experimental procedure: Pooled W-256 cells were suspended from as many line flasks of similar transfer number as were necessary to give 1-3 X 106 cells for each large flask, and 0.4-0.7 X 101 cells for each small flask. Only cells derived from a single suspension were used in any given experiment, to ensure a common origin for all cells. Growth rates were determined either by sacrificing duplicate small flasks at intervals for protein determinations1 or by performing daily cell counts on large flasks. As cell division appeared to enter the log phase of growth, usually 3-4 days after seeding, the large and small flasks were divided equally into two groups and additions were made to an enriched, appropriately concentrated, McCoy's medium just before the flasks were changed. DNA derived from W-256 tumors, dissolved in 0.01 M sodium phosphate buffer (pH 7.4), was added to the experimental group while the control flasks received an equal volume of 0.01 M sodium phosphate buffer. Both groups were maintained on added penicillin G (400 ,g/ml) without streptomycin. After this treatment was completed, the cells were again removed with 0.15% trypsin solution and resuspended in Hank's buffered salt solution, counted, and stained with trypan blue for animal injection and tRNA methylase studies.
In the experiment reported here, 0.6 X 106 cells were plated on each of 8 small flasks, and 2.4 X 106 cells on each of 12 large flasks. Fig. 1 by total protein1 before the flasks became overgrown on the fifth day. DNA was added 46 hr after plating to a final concentration of 120 MAg/ml. After 48 hr of treatment, a sufficient number of cells were removed from each group to inject 105 unstained cells into each of ten rats and to assay tRNA methylase activity. In addition, some of the DNA-treated cells were subcultured to standard medium for periods of 3 and 8 days, at which times rats were again injected and tRNA methylase activity was determined.
The medium in the remaining original flasks was changed to the special one containing either 120 M&g/ml of DNA or phosphate buffer, and cells were allowed to continue growing for an additional 24 hr, so that they had 72 hr of treatment in all. Again, aliquots were taken for animal injections and tRNA methylase determinations. All the flasks were overgrown and contained many floating cells unstained with trypan blue; the monolayer was therefore washed several times before trypsin application to be sure that only the firmly attached cells were used for animal injection and tRNA methylase activity.
To further assure ourselves that the tumor cells were healthy, we determined the 6-day Results. Animal studies: For the cells treated with DNA for both 48 and 72 hr, there was not only a considerable lag in the onset of the neoplasms, but there was a significant reduction in the number of animals that acquired and succumbed to the neoplasm in the 90-day interval of observation ( Fig. 2, top) . Not a single animal developed a tumor in the group receiving the small young viable cells treated with DNA for 96 hr (Fig. 2, tRNA methylase activity: The tRNA methylase activity of the tissue culture cells was determined after 48 and 75 hr of treatment, and again after the DNAtreated cells had been transferred back to the regular medium for 8 days. The results are recorded in Table 1 . After 48-and 72-hr exposures to DNA, there was a marked decrease in the specific activity of the tRNA methylase extracted from the cells, compared with that in buffer-treated controls. 8 days after the return of the cells to regular medium after hours' exposure to DNA, the tRNA methylase activity returned to the control or untreated values.
Freezing and storage of crude cell extracts resulted in loss of activity; therefore, only fresh extracts were used in all experiments.
In this particular experiment, the 105,000 X g supernates (crude enzyme source) were prepared from control W-256 cells and from cells treated for 24 hr with DNA. The supernates were dialyzed against two changes of buffer, 400-ml total, for 3 hr. Neutralized pH 5 supernates and precipitates were also prepared from the undialyzed 105,000 X g supernates. The neutralized supernate of the DNA-treated cells was also added to the dialyzed crude enzyme from the untreated cells. The enzyme activity was measured with and without added ammonium acetate in each case. The results are shown in Table 2 .
Ammonium acetate added to the reaction mixtures produced a more than 5-fold increase in the methylase activity of crude dialyzed preparations from DNA-treated cells compared with a slight decrease in activity from the control cells. However, ammonium acetate stimulated the pH 5 precipitate of both groups. The combination of neutralized pH 5 supernate from DNA-treated cells with dialyzed crude enzyme of control cells resulted in a marked reduction in the methylase activity of the control enzyme when the reaction was run without added ammonium acetate. With added ammonium acetate, the opposite effect was observed. Discussion. Continuous exposure of W-256 tissue culture cells to DNA prepared from the tumor does not impair the growth rate of these cells in tissue culture measured at 48 and 72 hr. However, these DNA-treated cells had a diminished ability to produce malignant tumors when inijected into the strain of rats from which the neoplasm originated. This effect may be demonstrated if the tissue culture cells are incubated with DNA for 90 min in the absence of prtein, but the effect is also evident in growing neoplastic cells in vitro within 24 hr when the medium contains not only protein but all the other necessary constituents for unaltered growth. The impaired oncogenicity was most apparent in cultures that were allowed to overgrow, and when the injected cells were limited to the newly formed, small floater cells that did not stain with trypan blue.
Coincident with the decrease in the oncogenicity is a decrease in tRNA methylase activity and the appearance of a tRNA methylase inhibitor. The presence of a tRNA methylase inhibitor is suggested by the decrease in enzyme specific activity of the tRNA methylases extracted from the DNA-treated cells (Table 1 and is associated with a rise in tRNA methylase activity. This also is evident in spontaneous malignancies of humans and experimental animals.'8 In neoplasia, the elevated tRNA methylase activity may be a reflection of a basic biochemical lesion-the failure to elaborate tRNA methylase inhibitors. By inducing such methylase inhibitors in malignant cells we have simultaneously reversed the biochemical lesion and the malignant state,.
